相关实验视频
Updated: Jul 23, 2025

09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
2.8K
在COVID-19疫苗接种后出现的新发病和复发的血栓性微血管病变
1Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, Donghu District, China.
Journal of medical virology
|July 12, 2023
概括
在接种COVID-19疫苗 (主要是mRNA疫苗) 后,血栓性微血管病变 (TMA) 呈现为TTP或aHUS. 病原发生涉及补体功能障碍,中性粒细胞激活和自身抗体,指导不同的治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 接种COVID-19疫苗后的血栓式微血管病变 (TMA) 是一种已知的但不太了解的并发症.
- 了解临床谱和潜在机制对于患者管理至关重要.
研究的目的:
- 描述COVID-19疫苗接种后TMA的临床特征和病原体.
- 为了比较TTP和非典型的血溶性尿素性综合征 (aHUS) 的表现和结果.
主要方法:
- 84个与COVID-19疫苗接种相关的TMA病例的回顾性审查.
- 对临床特征,疫苗类型,发病时间,实验室发现和治疗方式的分析.
- 调查潜在的病理机制,包括补充激活和自身抗体生成.
主要成果:
- TMA发作主要与mRNA COVID-19疫苗有关.
- 血栓性血栓塞性紫外线 (TTP) 和非典型的血溶性尿素性综合征 (aHUS) 显示出不同的人口和临床模式.
- TTP病例通常需要血交换,而aHUS病例使用非PEX疗法.
- 早期发病 (<7天) 在aHUS中更常见.
- 在aHUS中观察到较高的血清肌素水平.
结论:
- 接种COVID-19疫苗,特别是mRNA疫苗,可以触发TMA,表现为TTP或aHUS.
- 病原发生可能涉及补体失调,中性粒细胞激活和分子模拟诱导的自身抗体.
- 基于TMA亚型 (TTP与aHUS) 的量身定制的治疗策略对于最佳结果至关重要.
相关概念视频
Myocarditis III: Medical Management
9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
14
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
14
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Venous Thrombosis I: Introduction
13
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
13
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14

